Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. - Wikidata - awgldk - TriplyDB

Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.

Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.

http://www.wikidata.org/entity/Q33983618

about

Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes Real-time PCR in clinical microbiology: applications for routine laboratory testing.Isolate-dependent growth, virulence, and cell wall composition in the human pathogen Aspergillus fumigatus Eosinophils are recruited in response to chitin exposure and enhance Th2-mediated immune pathology in Aspergillus fumigatus infection Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal β-glucan from the immune system.Plasminogen alleles influence susceptibility to invasive aspergillosis.Early-onset heparin-induced thrombocytopenia after a 165-day heparin-free interval: case report and review of the literature.Detection of gliotoxin in experimental and human aspergillosis Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.Drosophila melanogaster as a model organism for invasive aspergillosis.Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype.Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.Cutaneous model of invasive aspergillosis.Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis.Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.Overview of vertebrate animal models of fungal infection.Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.The small GTPase RacA mediates intracellular reactive oxygen species production, polarized growth, and virulence in the human fungal pathogen Aspergillus fumigatus.The growing promise of Toll-deficient Drosophila melanogaster as a model for studying Aspergillus pathogenesis and treatment.Caspofungin acetate for treatment of invasive fungal infections.Killing of Candida albicans filaments by Salmonella enterica serovar Typhimurium is mediated by sopB effectors, parts of a type III secretion system.Standardization of an experimental murine model of invasive pulmonary aspergillosis.Collaborative Cross mice and their power to map host susceptibility to Aspergillus fumigatus infection The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy.Efficacy of caspofungin against Aspergillus flavus, Aspergillus terreus, and Aspergillus nidulans Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis.Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice.Antifungal pharmacokinetics and pharmacodynamics Characterization of a 5-azacytidine-induced developmental Aspergillus fumigatus variant.Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.Role of innate immune receptors in paradoxical caspofungin activity in vivo in preclinical aspergillosis.Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis.Posaconazole pharmacodynamic target determination against wild-type and Cyp51 mutant isolates of Aspergillus fumigatus in an in vivo model of invasive pulmonary aspergillosis VeA regulates conidiation, gliotoxin production, and protease activity in the opportunistic human pathogen Aspergillus fumigatus The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications.Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis Micafungin: a new echinocandin antifungal.Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.

P2860

Q24653633-0848FC72-254B-4256-9B76-AF490FB759A4 Q27472851-94F47E3B-194D-4AAC-B1D9-DCC30A1F5614 Q28388263-F9B44872-1343-4A19-8AFA-AF7B0E15B3B7 Q28392563-C4CDF799-6B97-48EE-AE03-B6266780A1C9 Q31129835-2C409568-DE15-4835-8BD5-AF3CED935E41 Q33345242-7B738B9B-1217-4687-BE6D-FC31A648B3E0 Q33366929-51F82030-1C69-4F69-82AD-45951A8A53EC Q33557456-7C434350-4D72-41EC-9DCD-8A65E735810C Q33689767-96DD33AC-F8FE-4C10-827A-1FC8D66A2B4B Q33709967-BAD36BE4-B433-4EC2-A2A7-C17FA2E7E890 Q33796715-9F5C249F-B052-4563-BD83-9FD45273AE49 Q33805542-40AB3746-0267-4B65-ABC5-47AC2123671D Q33826474-B50CD737-D2D3-42E4-9CF0-A402F4D7D4F6 Q34077069-5409AB0F-83F1-4758-B68A-72419AA619BE Q34143326-DA49CEBC-92BC-4895-A84C-83091C573EDE Q34175500-84D6ECFC-8EFC-4DAE-852F-E83326471667 Q34352109-26A17A09-B8CA-4F86-BA62-D6D4DC0714D8 Q34352222-42831CDD-F8A4-4146-B2D4-0E2EDB4439E6 Q34739183-8304A423-4D10-453B-BADD-2FFA30F2C5D7 Q34775725-57991565-FE46-4C6C-8F75-36D98FDCA04C Q35035091-82B2CB18-8077-46B0-BA10-2AD2B4F1297E Q35080883-2DB1C1F6-6880-4FE2-9DDA-EC0B6E0B5033 Q35091545-5A809363-7107-4C1A-BF41-7753EEA8D740 Q35145488-531B4C7F-485A-446D-822C-57EC14168F1B Q35185757-4E0AE194-39FD-4FA7-9504-2A85817E00F5 Q35215384-FA500E06-1DDE-4821-8C98-697314CFE24E Q35472340-1E170EF7-1036-42AC-8285-2A4472D8D369 Q35647688-8C0ADA69-E2E9-4EFD-8212-8881D2D246F1 Q35663841-158D3516-AE41-46B3-898D-C351272DB651 Q35693769-66E2BD23-698D-4EE2-9AE7-8D82DF47D8F3 Q35758926-85F4F7B8-C762-4E98-AF6F-17B061D4A409 Q36171611-71C8F53F-1C22-433A-ACE2-1BCBD053C157 Q36235415-74FC111B-8C0F-453C-9824-30F747437E1A Q36425073-071B58D6-DDC3-409B-8FA1-EDD0F32E0ACE Q36505539-AE41991E-B391-46ED-9E26-C7851D4DC2C7 Q36506547-7AEFBD24-182C-4948-95E7-8299853D7944 Q36626518-8D16A62C-D15B-4DD5-B5F5-6C244B65B854 Q36641630-379DD32E-80EF-402D-90EE-1D477030380E Q36693843-921CFFC4-09FC-46CC-BE2F-06C1D0B879B9 Q36744831-872E6F27-A1F0-4DE3-AD30-BC6DE9BD36CF

P2860

Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.

http://www.wikidata.org/entity/Q33983618

description

2001 nî lūn-bûn

@nan

2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Quantitative PCR assay to meas ...... ficacy of caspofungin acetate.

@ast

Quantitative PCR assay to meas ...... ficacy of caspofungin acetate.

@en

type

label

Quantitative PCR assay to meas ...... ficacy of caspofungin acetate.

@ast

Quantitative PCR assay to meas ...... ficacy of caspofungin acetate.

@en

prefLabel

Quantitative PCR assay to meas ...... ficacy of caspofungin acetate.

@ast

Quantitative PCR assay to meas ...... ficacy of caspofungin acetate.

@en

P1433

Q33983618-7492700D-FE6F-4EB2-BCB9-A767CB468312

P1476

Q33983618-283145B0-67C2-4259-B2DC-1AA750BFECCC

P2093

Q33983618-047A9E26-5361-4680-8040-DC7E2D9BAA26

Q33983618-11AED0A8-42F3-47CB-B6C6-0A29269E5DEC

Q33983618-1701CA6F-89B0-424A-8A20-4EDAE4CB42E9

Q33983618-9D714B6C-8781-4463-A598-A5B05D41E0AB

Q33983618-AB6AD8C3-3689-46E1-95A9-713F431AEC94

Q33983618-BFD82727-FBF3-4360-A5D7-0C7948F35933

Q33983618-C9078FBF-3AE7-446A-817E-E5A6F582D7DB

Q33983618-E3688006-F85D-4217-A808-208E47C11DD1

Q33983618-F5188705-2F26-4B37-BCF1-58EAC8462077

P2860

Q33983618-0319B9D6-7DDE-4C56-B219-60413CB5E2EA

Q33983618-0C21C168-D954-425D-8EBB-9310EBF8CCC3

Q33983618-0F276FAC-03D3-4B77-AE28-9F2C44D0F9DF

Q33983618-12BED2B1-B120-4AF5-96D2-2A134FB42047

Q33983618-17CAD1B2-F717-4253-BD67-8386F2C18D4B

Q33983618-2207FF12-4BB0-4253-B3CA-27D5D67AFA08

Q33983618-2464EF2D-0024-46E4-BEE8-1B40DA3740DD

Q33983618-25BC700D-BA5F-4DC6-8626-F61C6630E894

Q33983618-272F2DDC-5AE4-4AE4-B2D7-4FB1C38FEF8A

Q33983618-27AF70CF-8E05-42DD-926E-94F54D0DC473

P304

Q33983618-9D976263-594E-46D5-9BF0-7559362BB78C

P31

Q33983618-5DE67908-373C-44BD-9CC9-CA9C713209D4

P356

Q33983618-EA2B6BEA-FEED-481C-808D-644953EF2400

P407

Q33983618-68FABEB6-5248-4AE2-8C7F-BD0E0DF2BDCB

P433

Q33983618-4B71E5B0-5F97-4316-BA9D-C4450D4CFE8E

P478

Q33983618-13A0FB82-B802-4BDC-A03D-5588539739DD

P577

Q33983618-5035620B-F969-46F7-8E29-68E6B85D3134

P5875

Q33983618-03605EC6-16BA-419F-BF49-D84826C9E72F

P698

Q33983618-B85361DA-91B9-48E2-BCAC-881377445857

P921

Q33983618-353DC04E-01C3-4053-A81C-4D9F46771E73

Q33983618-D979C9EB-CED7-4C71-9200-5455FC764337

P932

Q33983618-9F8C68DB-9285-4024-A78A-9645BAED8448

P356

AAC.45.12.3474-3481.2001

P1433

Antimicrobial Agents and Chemotherapy

P1476

Quantitative PCR assay to meas ...... ficacy of caspofungin acetate.

@en

P2093

A M Flattery

http://www.w3.org/2001/XMLSchema#string

C J Gill

http://www.w3.org/2001/XMLSchema#string

C M Douglas

http://www.w3.org/2001/XMLSchema#string

D M Schmatz

http://www.w3.org/2001/XMLSchema#string

G K Abruzzo

http://www.w3.org/2001/XMLSchema#string

J C Bowman

http://www.w3.org/2001/XMLSchema#string

J W Anderson

http://www.w3.org/2001/XMLSchema#string

P A Liberator

http://www.w3.org/2001/XMLSchema#string

V B Pikounis

http://www.w3.org/2001/XMLSchema#string

P2860

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis

Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice

Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis

Real time quantitative PCR

Aspergillus fumigatus and aspergillosis

Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus.

P304

3474-3481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.45.12.3474-3481.2001

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2001-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11646404

http://www.w3.org/2001/XMLSchema#string

P698

11709327

http://www.w3.org/2001/XMLSchema#string

P921

Aspergillus fumigatus

P932

90856

http://www.w3.org/2001/XMLSchema#string